Geneva: World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus talked over the issue of the emergency use listing of Bharat Biotech's COVID-19 vaccine (Covaxin) and resumption of supplies of the Serum Institute of India (SSI)-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya.

Taking to Twitter, World Health Organisation chief Tedros Ghebreyesus on Tuesday said, “Had a call with @mansukhmandviya, India's Health Minister, to discuss India's ongoing COVID19 vaccination programme; the need for a global pandemic agreement; digital health; & traditional medicine." "We welcome India's support to strengthen WHO, incl. via flexible, sustainable financing,” Ghebreyesus said. Tedros further said that he also discussed vaccine equity issues with Mandaviya. 

Had a call with @mansukhmandviya, ???????? Health Minister, to discuss #India's ongoing #COVID19 vaccination program; the need for a global pandemic agreement; digital health; & traditional medicine. We welcome ????????'s support to strengthen WHO, incl. via flexible, sustainable financing. pic.twitter.com/XhCVIhZBIe

— Tedros Adhanom Ghebreyesus (@DrTedros) October 19, 2021

Health Minister Mandaviya also took to Twitter and confirmed he had a 'detailed interaction with the Tedros  , who was also accompanied by other senior officials of the global health agency “on various issues related to health, including pandemic management and WHO reforms.  Iin a Tweet Health Minister Mandaviya said, “DG WHO lauded the mammoth efforts undertaken by the Indian government for COVID19 vaccination.”

Covaxin: DCGI approves Covaxin for kids aged between 2-18 years

Guterres appeals for USD 8 billion to equitably vaccinate 40% of global population in 2021

Will Covaxin be allowed by WHO or not? Decision to be taken today